What is Injection Lipolysis?
Injection lipolysis is a controversial cosmetic procedure in which medicate mixtures are infused into patients with the goal of destroying fat cells. It is additionally connected in cosmetic surgeries to the patients to reduce the number of fat cells. Injection lipolysis is a non-surgical alternative in which drug blends such as deoxycholic acid, in combination with vitamin E, l-carnitine, collagenase, isoproterenol, and hyaluronidase are infused to destroy fat cells. In the US and in Canada the only FDA-approved fat dissolving injection is deoxycholic acid and it is indicated only for the treatment of sub mental fat known as the double chin. Injection lipolysis is a method using thin needles injecting into the skin solutions containing substances that break down fats in fat cells. These arrangements usually contain phosphatidylcholine. It is a natural substance, which is obtained from the soybeans but also is naturally in the human body.
Attributes | Details |
---|
Study Period | 2017-2027 |
Base Year | 2021 |
Unit | Value (USD Million) |
Key Companies Profiled | Valeant Pharmaceuticals International, Inc. (United States), Allergan plc. (Ireland), Alma Lasers, Ltd. (Israel), Cynosure, Inc. (United States), Sciton, Inc. (United States), Solta Medical Inc. (United States), Lumenis Ltd. (Israel), Syneron Medical Ltd. (United States) and Apollo Cosmetic Clinics (India) |
The study covers a detailed analysis segmented by key business segments i.e. and major geographies. Research Analyst at AMA predicts that United States Players will contribute to the maximum growth of Global Injection Lipolysis market throughout the predicted period.
The competition is expected to become even more intense in the years to come due to the entry of several new players in the market. To help clients improve their revenue shares in the market, this research study provides an in-depth analysis of the markets competitive landscape and offers information on the products offered by various leading companies. Additionally, this Injection Lipolysis market report suggests strategies that Players can follow and highlights key areas they should focus on, in order to take maximum benefits of growth opportunities.
The report offers several leading Players, some of them are Valeant Pharmaceuticals International, Inc. (United States), Allergan plc. (Ireland), Alma Lasers, Ltd. (Israel), Cynosure, Inc. (United States), Sciton, Inc. (United States), Solta Medical Inc. (United States), Lumenis Ltd. (Israel), Syneron Medical Ltd. (United States) and Apollo Cosmetic Clinics (India).
Food and Drug Administration (FDA) Approval: Currently, KybellaTM is the only FDA approved injectable solution for lipolysis. Physicians who wish to use other agents in the literature for adipose reduction may be subject to some degree of liability as the FDA may review individual occurrences on a case-by-case basis for enforcement action.
The companies are exploring the market by adopting expansions, investments, and new service launches and collaborations as their preferred strategies. The players are exploring new geographies through expansions and acquisitions across the globe to gain a competitive advantage through combined collaborations.
Injection Lipolysis Market Dynamics:
Attributes | Details |
---|
Growth Drivers | - Growing Awareness Towards the fat Reduction Process
- Increasing Population of Obese People
- Increasing Demand for Non-Invasive Procedures
- Demand for Cosmetic surgeries
|
Major Trends | - Many Women Prefer Undergoing Cosmetic Surgery Rather Than Changing Their Lifestyle
|
Restraints | - Side Effects of Treatment
|
Road Blocks / Challenges | - High Cost of Treatment
- Presence of Other Fat Breakdown Techniques
|
Gaps & Opportunities | - Rise in Medical Tourism
- Increase in Adoption of Body Contouring
- High Market Potential in Untapped Emerging Economies
|
Key highlights of the Global Injection Lipolysis market Study:
CAGR of the market during the forecast period 2021-2027
In-depth information on growth factors that will accelerate the Injection Lipolysis market in next few years.
Detailed Insights on futuristic trends and changing consumer behavior
Forecast of the Global Injection Lipolysis market size and its contribution to the parent market by type, application and by country.
A broad view of customer demand
Uncover markets competitive landscape and in-depth information on various Players
Comprehensive information about factors that will challenge the growth of Injection Lipolysis Players
Transformation and Important Triggers:
Business transformation has taken hold across the broad corporate landscape due to the confluence of several important triggers, including:
A tipping point in globalization
A major slowdown in Western economies
Significant shifts in technology and cost structure
The challenges of regulatory compliance
New forms of competition developing
Research Methodology:
The top-down and bottom-up approaches are used to estimate and validate the size of the Global Injection Lipolysis market.
In order to reach an exhaustive list of functional and relevant players, various industry classification standards are closely followed such as NAICS, ICB, and SIC to penetrate deep into important geographies by players, and a thorough validation test is conducted to reach the most relevant players for survey in Injection Lipolysis market.
In order to make a priority list sorting is done based on revenue generated based on the latest reporting, using paid databases such as Factiva, Bloomberg, etc.
Finally the questionnaire is set and specifically designed to address all the necessities for primary data collection after getting prior appointment> by targeting key target audience that includes Venture Capitalists and Private Equity Firms, New Entrants/Investors, Analysts and Strategic Business Planners, Government Regulatory and Research Organizations, Raw Material Supliers and End-Use Industries.
This helps us to gather the data for the players revenue, operating cycle and expense, profit along with product or service growth, etc.
Almost 70-80% of data is collected through primary medium and further validation is done through various secondary sources that include Regulators, World Bank, Association, Company Website, SEC filings, OTC BB, Annual reports, press releases, etc.